1 Mar 2023

Reference: CIR-2023-00000024

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

Recall of Pharmaceutical Product Tetracycline Hyrochloride Ophthalmic Ointment USP 1%

Safety update of pharmaceutical products containing opioid agonist (including loperamide) - Imodium®(Loperamide)

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Tetracycline Hyrochloride Ophthalmic Ointment USP 1% - سحب منتج الصيدلاني ---.pdf

download

Imodium ( Loperamide )++.docx.pdf

download